黄色视频不卡_午夜福利免费观看在线_亚洲国产精品999在线_欧美绝顶高潮抽搐喷水_久久精品成人免费网站_晚上一个人看的免费电影_国产又色又爽无遮挡免费看_成人国产av品久久久

    1. <dd id="lgp98"></dd>
      • <dd id="lgp98"></dd>
        1. 深圳遠揚化學(xué)技術(shù)有限公司
          中級會員 | 第9年

          15012456311

          當(dāng)前位置:深圳遠揚化學(xué)技術(shù)有限公司>>藥物雜質(zhì)對照品>>雜質(zhì)>> 利格列汀雜質(zhì) 利拉利汀雜質(zhì)

          利格列汀雜質(zhì) 利拉利汀雜質(zhì)

          參   考   價: 100

          訂  貨  量: ≥1 

          具體成交價以合同協(xié)議為準

          產(chǎn)品型號

          品       牌其他品牌

          廠商性質(zhì)生產(chǎn)商

          所  在  地深圳市

          更新時間:2022-03-17 15:16:26瀏覽次數(shù):1436次

          聯(lián)系我時,請告知來自 化工儀器網(wǎng)
          利格列汀雜質(zhì) 利拉利汀雜質(zhì)
          Linagliptin Impurity
          提供NMR,HPLC,MS圖譜及COA證書,新藥申報可用
          全部雜質(zhì)現(xiàn)貨供應(yīng),*,并可接受定制。
          25mg/50mg/100mg等多種規(guī)格可選。

          利格列汀雜質(zhì) 利拉利汀雜質(zhì)??   產(chǎn)品介紹:
          規(guī)格:10mg/25mg/50mg/100mg等多種規(guī)格可選。
          用途:實驗研發(fā),藥品申報檢測,不得用于臨床醫(yī)學(xué)診斷。
          隨貨提供:所有雜質(zhì)對照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。

           

          國產(chǎn)進口品牌皆有銷售,產(chǎn)品庫時常更新,部分雜質(zhì)長期備有庫存,可當(dāng)天發(fā)貨,另外,我司有專業(yè)研發(fā)團隊,可提供雜質(zhì)定制服務(wù),以zui大可能的滿足您對雜質(zhì)對照品的選購需求。

           

          利格列汀雜質(zhì) 利拉利汀雜質(zhì)??   雜質(zhì)列表:

          Linagliptin(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 1 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 22-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
          Linagliptin Impurity 3(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 4(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 5N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
          Linagliptin Impurity 6(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
          Linagliptin Impurity 78-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
          Linagliptin Impurity 8(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
          Linagliptin Impurity 98-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 10(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
          Linagliptin Impurity 11(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 128-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 13(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
          Linagliptin Impurity 14(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 15(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 16(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
          Linagliptin Impurity 17(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 187-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 19N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
          Linagliptin Impurity 20(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
          Linagliptin Impurity 21(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
          Linagliptin Impurity 22(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
          Linagliptin Impurity 23(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 24(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
          Linagliptin Impurity 25(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
          Linagliptin Impurity 26(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

           

          ??       我司主營醫(yī)藥標準品及雜質(zhì)對照品,以下雜質(zhì)備有庫存,可當(dāng)天發(fā)貨,*: 依魯替尼雜質(zhì),奧貝膽酸雜質(zhì),依美斯汀雜質(zhì),卡格列凈雜質(zhì),利格列汀雜質(zhì),西格列汀雜質(zhì),埃索美拉唑雜質(zhì),LCZ696雜質(zhì),恩雜魯胺雜質(zhì),艾曲波帕雜質(zhì),非布司他雜質(zhì),托匹司他雜質(zhì),樂伐替尼雜質(zhì),奧拉帕尼雜質(zhì),阿維巴坦雜質(zhì),奧美拉唑雜質(zhì),普卡必利雜質(zhì),西他沙星雜質(zhì),泊沙康唑雜質(zhì),替格瑞洛雜質(zhì),托法替尼雜質(zhì),決奈達隆雜質(zhì),阿奇霉素雜質(zhì)等。 

           

           

          ??    美國劍橋CIL標準品部分產(chǎn)品列表:

          DLM-277-PK                HEXANOIC ACID (D11, 98%)

          CLM-9146-0.01            5-ALPHA-DIHYDROTESTOSTERONE 97% CHEMICAL PURITY (2,3,4-13C3,99%)

          EDF-4143-1                 CALIBRATION CURVE, CDC1 DIOXIN, FURAN, & PCB IN TISSUE IN NONANE

          JR-D45-25                   1,2,4,6,7,9-HEXACDD UNLABELED ~25 NG/ML IN NONANE

          CGM-1000-CN-20-S      BIOEXPRESS CELL GROWTH MEDIA (U-13C, 19%; U-15N, 98%) (10X CONCENTRATE)

          DLM-2084-PK               L-DOPA (RING-D3, 98%)

          H-922                         ALPHA-HYDROXYMIDAZOLAM UNLABELED 1.0 MG/ML IN METHANOL

          CRLM-4396-0               CHROMIUM-54 OXIDE (54Cr)

          CLM-1896-PK               INDOLE-3-ACETIC ACID (PHENYL-13C6, 99%)

          H-049                         HYDROMORPHONE (D6, 98%) 100 UG/ML IN METHANOL

          EC-5000                      WHO COPLANAR & MONO-ORTHO PCB + PCB-170 & PCB-180 UNLABELED 2 UG/ML IN ISOOCTANE

          CDLM-7754-PK             SUCCINIC ACID (13C4, 99%; 2,2,3,3-D4, 98%)

          DLM-143-5X1               1,1,1,3,3,3-HEXAFLUOROISOPROPANOL-D2 (D, 98%)

          PCB-170-C                  2,2',3,3',4,4',5-HEPTACB UNLABELED

          CLM-3876-PK               SODIUM OCTANOATE (1,2,3,4-13C4, 99%)

          CNLM-6696-PK             CELL FREE AMINO ACID MIX (20 AA) (U-13C, 97-99%+; U-15N, 97-99%)

          ES-5038-1-10X-1         CLP VOLATILES NON-KETONE DMC 10X STOCK SOLUTION 1000 UG/ML IN METHANOL-OD

          EC-1436-1.2                2,2',3,4,4',5'-HEXACB (PCB-138) (13C12, 99%) 40+/-2 UG/ML IN NONANE

          CLM-2093-MPT-PK        ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED

          DLM-10-PK                  DIMETHYL SULFOXIDE-D6 (D, 99.9%)

          EDF-5429-CS8H           TWO COLUMN DIOXIN & FURAN CALIBRATION SOLUTION CS8H (UNLABELED/13C12, 99%)

          CLM-156-MPT-PK          SODIUM ACETATE (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED

          DLM-6196-1.2              METHYLPHOSPHONIC ACID (METHYL-D3, 98%) 100 UG/ML IN METHANOL

          CLM-2456-PK               D-XYLOSE (1,2-13C2, 99%)

          PCB-166-C                  2,3,4,4',5,6-HEXACB UNLABELED

          CDLM-7582-SL-1          HIS-UBIQUITIN DC (13C, 98%; D, 98%) *DISCONTINUED*

          ULM-9091-1.2              TRIPHENYL PHOSPHATE UNLABELED 1 MG/ML IN ACETONITRILE

          DLM-4721-0.5              L-CYSTEINE-N-FMOC, S-TRITYL (3,3-D2, 98%)

           

          更多關(guān)于   ??    的產(chǎn)品信息,請我司獲取詳情~

           

          會員登錄

          ×

          請輸入賬號

          請輸入密碼

          =

          請輸驗證碼

          收藏該商鋪

          X
          該信息已收藏!
          標簽:
          保存成功

          (空格分隔,最多3個,單個標簽最多10個字符)

          常用:

          提示

          X
          您的留言已提交成功!我們將在第一時間回復(fù)您~
          撥打電話
          在線留言
          普兰县| 鄂伦春自治旗| 新密市| 香港 | 盐池县| 如东县| 昂仁县| 增城市| 濉溪县| 闻喜县| 广丰县| 安徽省| 长乐市| 兴和县| 贵南县| 醴陵市| 吉首市| 晋中市| 花垣县| 静宁县| 礼泉县| 高平市| 桂东县| 金沙县| 成安县| 鲁山县| 夏邑县| 岳阳县| 天长市| 嘉黎县| 云龙县| 万安县| 博乐市| 荔波县| 印江| 大田县| 梧州市| 湘潭市| 凤台县| 循化| 聊城市|